These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 26546333)
41. The Pandemic Influenza Preparedness (PIP) Framework: strengthening laboratory and surveillance capacities in the Western Pacific Region, 2014-2017. Chugh H; Samaan G; Resnikoff T; Bergeri I; Barragan J; Dueger E Western Pac Surveill Response J; 2020; 11(4):32-35. PubMed ID: 34046239 [No Abstract] [Full Text] [Related]
42. Influenza and the work of the World Health Organization. Kitler ME; Gavinio P; Lavanchy D Vaccine; 2002 May; 20 Suppl 2():S5-14. PubMed ID: 12110248 [TBL] [Abstract][Full Text] [Related]
43. Department of Defense Global Laboratory-Based Influenza Surveillance: 1998-2005. Owens AB; Canas LC; Russell KL; Neville JS; Pavlin JA; MacIntosh VH; Gray GC; Gaydos JC Am J Prev Med; 2009 Sep; 37(3):235-41. PubMed ID: 19666159 [TBL] [Abstract][Full Text] [Related]
44. Evaluation of a laboratory capacity strengthening project: a case of the summative assessment of the African Field Epidemiology Network (AFENET) laboratory project 2010 - 2016. Kabugo H; Ashaba D; Mosha F; Babirye R; Kihembo C; Maeda M; Hay K; Namusisi O; Nsubuga P Pan Afr Med J; 2018; 30():297. PubMed ID: 30637081 [TBL] [Abstract][Full Text] [Related]
45. A global review of national influenza immunization policies: Analysis of the 2014 WHO/UNICEF Joint Reporting Form on immunization. Ortiz JR; Perut M; Dumolard L; Wijesinghe PR; Jorgensen P; Ropero AM; Danovaro-Holliday MC; Heffelfinger JD; Tevi-Benissan C; Teleb NA; Lambach P; Hombach J Vaccine; 2016 Oct; 34(45):5400-5405. PubMed ID: 27646030 [TBL] [Abstract][Full Text] [Related]
46. Pandemic Influenza Readiness Report on Laboratory and Epidemiology Capacity-United States and Territories, 2015. Lowe L; Dopson SA; Budd AP Health Secur; 2018; 16(4):239-243. PubMed ID: 30096246 [TBL] [Abstract][Full Text] [Related]
47. How close are countries of the WHO European Region to achieving the goal of vaccinating 75% of key risk groups against influenza? Results from national surveys on seasonal influenza vaccination programmes, 2008/2009 to 2014/2015. Jorgensen P; Mereckiene J; Cotter S; Johansen K; Tsolova S; Brown C Vaccine; 2018 Jan; 36(4):442-452. PubMed ID: 29287683 [TBL] [Abstract][Full Text] [Related]
48. FluView and FluNet: Tools for Influenza Activity and Surveillance. Charbonneau DH; James LN Med Ref Serv Q; 2019; 38(4):358-368. PubMed ID: 31687905 [TBL] [Abstract][Full Text] [Related]
50. Evaluation of the WHO/CDC Syphilis Serology Proficiency Programme to support the global elimination of mother-to-child transmission of syphilis: an observational cross-sectional study, 2008-2015. Hopkins AO; Trinh T; Fakile YF; Pillay A; Taylor MM; Kersh E; Kamb M BMJ Open; 2020 Jan; 10(1):e029434. PubMed ID: 31924629 [TBL] [Abstract][Full Text] [Related]
52. Strengthening national decision-making on immunization by building capacity for economic evaluation: Implementing ProVac in Europe. Blau J; Hoestlandt C; D Clark A; Baxter L; Felix Garcia AG; Mounaud B; Mosina L Vaccine; 2015 May; 33 Suppl 1():A34-9. PubMed ID: 25919171 [TBL] [Abstract][Full Text] [Related]
53. Cost analysis of an integrated vaccine-preventable disease surveillance system in Costa Rica. Toscano CM; Vijayaraghavan M; Salazar-Bolaños HM; Bolaños-Acuña HM; Ruiz-González AI; Barrantes-Solis T; Fernández-Vargas I; Panero MS; de Oliveira LH; Hyde TB; Vaccine; 2013 Jul; 31 Suppl 3(0 3):C88-93. PubMed ID: 23777698 [TBL] [Abstract][Full Text] [Related]
54. Update: influenza activity--United States and worldwide, and composition of the 1993-94 influenza vaccine. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 1993 Mar; 42(10):177-80. PubMed ID: 8446091 [TBL] [Abstract][Full Text] [Related]
55. Stakeholders' assessment of US Centers for Disease Control and Prevention's contributions to the development of National Public Health Institutes in seven countries. Woldetsadik MA; Fitzpatrick K; Del Castillo L; Miller B; Jarvis D; Carnevale C; Ravat F; Cassell CH; Williams A; Young SK; Clemente J; Baggett HC; Bratton S J Public Health Policy; 2021 Dec; 42(4):589-601. PubMed ID: 34811465 [TBL] [Abstract][Full Text] [Related]
57. Establishing a national influenza sentinel surveillance system in a limited resource setting, experience of Sierra Leone. Kebede S; Conteh IN; Steffen CA; Vandemaele K; Wurie I; Alemu W; Kuti-George F; Dafae F; Jambai A; Yahaya AA; Kasolo FC Health Res Policy Syst; 2013 Jun; 11():22. PubMed ID: 23800108 [TBL] [Abstract][Full Text] [Related]
58. Future directions for the European influenza reference laboratory network in influenza surveillance. Goddard N; Rebelo-de-Andrade H; Meijer A; McCauley J; Daniels R; Zambon M Euro Surveill; 2015 Jul; 20(30):. PubMed ID: 26250071 [TBL] [Abstract][Full Text] [Related]
59. Stakeholders' perceptions of 10years of the Global Action Plan for Influenza Vaccines (GAP) - Results from a survey. Nannei C; Goldin S; Torelli G; Fatima H; Kumar K; Bubb-Humfryes O; Stenson B; Sparrow E Vaccine; 2016 Oct; 34(45):5393-5399. PubMed ID: 27646029 [TBL] [Abstract][Full Text] [Related]
60. United States of America Department of Health and Human Services support for advancing influenza vaccine manufacturing in the developing world. Perdue ML; Bright RA Vaccine; 2011 Jul; 29 Suppl 1():A48-50. PubMed ID: 21684430 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]